Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Debt Ratio (2016 - 2025)

China Pharma Holdings filings provide 16 years of Debt Ratio readings, the most recent being 0.06 for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 62.56% to 0.06 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.06, a 62.56% decrease, with the full-year FY2025 number at 0.06, down 62.56% from a year prior.
  • Debt Ratio hit 0.06 in Q4 2025 for China Pharma Holdings, down from 0.12 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.28 in Q3 2022 to a low of 0.06 in Q4 2025.
  • Median Debt Ratio over the past 5 years was 0.17 (2024), compared with a mean of 0.17.
  • Biggest five-year swings in Debt Ratio: skyrocketed 122.79% in 2021 and later tumbled 62.56% in 2025.
  • China Pharma Holdings' Debt Ratio stood at 0.19 in 2021, then dropped by 28.19% to 0.14 in 2022, then grew by 8.06% to 0.15 in 2023, then rose by 14.86% to 0.17 in 2024, then tumbled by 62.56% to 0.06 in 2025.
  • The last three reported values for Debt Ratio were 0.06 (Q4 2025), 0.12 (Q3 2025), and 0.2 (Q2 2025) per Business Quant data.